Groundbreaking, three-part coverage of AdMeTech’s research program in prostate MRI and its potential impact on screening, diagnosis and treatment by the Wall Street Journal. April 2009
The Man, the Gland, the Dilemmas
You’ve been getting annual blood tests to check for prostate cancer. But two big studies in the New England Journal of Medicine just found that screening for PSA — prostate specific antigen — doesn’t save many lives. Should you keep checking it?
You’ve been diagnosed with prostate cancer and after the shock comes confusion.
Should you treat it fast with surgery but face an immediate risk of sexual and urinary problems? Or should you opt for weeks of daily radiation treatments and side effects that set in more slowly? Should you also use hormone therapy that may shrink the cancer — and your sex drive along with it? Or should you just monitor your cancer and hope you’ll catch it if it starts to spread out of control? (Read More)